A man was given two years to live after a colon cancer diagnosis. Now he's healthy thanks to combination of medicine and the right care team.

While rates of cancer diagnosis under age 50 have risen in recent years, this has not translated into increased cancer ...

J&J shares positive long-term results of Rybrevant study for RAS/BRAF wild-type metastatic colorectal cancer at ASCO ...

Pfizer shared new trial data showing its cancer drug combo helped shrink tumors more often than standard treatment in ...

Johnson & Johnson today announced new longer follow-up results from the investigational Phase 1b/2 OrigAMI-1 study evaluating amivantamab-vmjw, a bispecific antibody targeting epidermal growth factor ...

GLP-1 receptor agonists may be superior to aspirin for primary prevention of colorectal cancer, according to study results ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced its Shield blood test for ...

CITCCA study data demonstrate strong association between ctDNA status and recurrence risk in stage I-III colorectal cancerMORRISVILLE, N.C.--(BUSINESS WIRE)--#ASCOGI--SAGA Diagnostics, a pioneer in ...

New data indicate that nonoperative surveillance after removing a malignant colorectal polyp can achieve high rates of rectal ...

VANCOUVER, BC, Dec. 31, 2025 /CNW/ -- The precision oncology market surged to $139.4 billion in 2025 and is racing toward $317.5 billion by 2035([1]) , driven by a fundamental shift in cancer ...

Nothing prepares you for the moment you’re told you have cancer. But I’ll go one further. Nothing prepares you for telling other people that you have cancer. I warned my wife, while getting in a cab ...

STAFFORD, Texas, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, ...